In AIDS-Related Lymphoma, Outcomes Worse With Hypoalbuminemia


FRIDAY, June 24, 2022 — For patients with AIDS-related lymphoma (ARL), hypoalbuminemia predicts inferior outcome, according to a study published online June 18 in Infectious Agents and Cancer.

Jinxin Zhang, from Nanfang Hospital in Guangzhou, China, and colleagues retrospectively analyzed de novo ARL patients from 2013 to 2019 to examine factors correlating with progression-free survival (PFS) and overall survival (OS). Eighty-six ARL patients were enrolled and followed for a median of 34 months.

The researchers found that the OS and two-year PFS rates were 37.5 and 35.4 percent, respectively, in the cohort. Inferior survival was predicted by older age and hypoalbuminemia in multivariate models. Worse OS and two-year PFS were seen for ARL patients with hypoalbuminemia, which was associated with poor Eastern Cooperative Oncology Group performance status and a higher International Prognosis Index score.

“We showed that hypoalbuminemia is a simple and effective prognostic factor in AIDS-related lymphoma patients,” the authors write. “For ARL patients with hypoalbuminemia, closer follow-up and timely intervention are necessary.”

Abstract/Full Text

© 2022 HealthDay. All rights reserved.

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.



Source link

Published by Drugs.Com Know More. Be Sure
Managed by Pharma Enthusiast, To claim this account, mail us at pharmamedia.in@gmailcom
Get Connected!
Come and join Pharma Community. Expand your network in Pharma!

Comments

No comments yet